Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
McKesson
Harvard Business School
AstraZeneca

Last Updated: March 22, 2023

Litigation Details for Amgen Inc. v. Sanofi (D. Del. 2014)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in Amgen Inc. v. Sanofi
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .
Biologic Drugs cited in Amgen Inc. v. Sanofi
The biologic drugs covered by the patents cited in this case are See Plans and Pricing and See Plans and Pricing .

Details for Amgen Inc. v. Sanofi (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-10-17 1 1400(b). THE PATENTS-IN-SUIT 20. On October 22, 2013, United States Patent No. 8,563,698 (“the ’698 …United States Patent Nos. 8,563,698, 8,829,165, and 8,859,?41. This action arises out of Defendants’ current… COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT filed with jury…. COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY .]UDGMENT OF PATENT INFRINGEMENT Plaintiff…for its Complaint for Patent Infringement and for a Declaratory Judgment of Patent ]nfringement against External link to document
2019-08-28 1050 Opinion - Memorandum Opinion infringement of U.S. Patent Nos. 8,583 ,698 ("the ' 698 patent"), 8,829,165 ("the '…' 165 patent, claim 7 of the '741 patent, and claim 24 of the ' 914 patent. (D.I. 23 …. (' 741 patent, cl. 1-2, 7; ' 165 patent, cl. 1, 19, 29).). This patent language does not…#x27; 165 patent"), and 8,859,741 ("the ' 741 patent"). (D.I. 1, 10, 184). Plaintiffs…of infringement of U.S. Patent Nos. 8,871 ,913 ("the ' 913 patent"), 8,871 ,914 (" External link to document
2019-10-11 1062 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,563,698; 8,829,165; 8,859,741…2014 3 October 2019 1:14-cv-01317 830 Patent Plaintiff District Court, D. Delaware External link to document
2015-10-20 151 parties referenced related U.S. Patent Nos. 8,563,698 ("the '698 patent") having the same specification…'165 patent; claims 1and4 of the '741 patent; and claim 16 of the '914 patent. The parties…disputed claim language of U.S. Patent Nos. 8,829, 165 ("the '165 patent"), 1 8,859,741 ("…quot;the '741 patent"), and 8,871,914 ("the '914 patent") shall be construed … 1 As the patents share a specification, all citations are to the '165 patent unless otherwise External link to document
2015-11-05 163 Regarding Infringernent of Clairn 24 of U.S. Patent No. 8,871,914; (5) the EXpert Report of Evan A. Stein,…Regarding Infringement of SElected Claims of the Patents-at-Issue; (4) the Opening Expert Report of Anthony…Rees Regarding Infringement of Claim 24 of U.S. Patent No. 8,871,941; and (5) the Expert Report of Evan…Regarding Infringement of the Selected Claims of the Patents-at-Issue; (4) the Opening Expert Report of Anthony…2014 3 October 2019 1:14-cv-01317 830 Patent Plaintiff District Court, D. Delaware External link to document
2016-01-28 184 THE PATENTS-IN-SUIT 25. On October 22, 2013, United States Patent No. 8,563,698 (“the ’698 Patent”) entitled…United States Patent Nos. 8,563,698, 8,829,165, _8,859,74], 8,871,913, 8,871,914, 8,883,983, and 8,889,834…Second Amended Complaint for Patent Infringement and Declaratory Judgment of Patent Infringement] against Aventisub…for its Complaint for Patent Infn`ngement and for a Declaratory Judgment of Patent Infn'ngement against…This is an action for patent infringement and for a declaratory judgment of patent infringement of United External link to document
2016-02-17 226 Selected claims of U.S. Patent Nos. 8,829,165 ("the '165 patent"), 8,859,741 ("…quot;the '741 patent"), and 8,871,914 ("the '914 patent"). …out-license its patent rights to a competitor where the technology covered by the patent rights is technology… and (2) Defendants' Expert Opinions as to the Patents' Disclosure of Representative Species]. Signed …antibodies that were not disclosed in the selected patents. (D.1.191) Defendants' motion seeks to exclude External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Boehringer Ingelheim
Medtronic
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.